Ghorbani R P, Shokouh-Amiri H, Gaber L W
University of Tennessee-Memphis, Department of Pathology 38163, USA.
Mod Pathol. 1996 Jun;9(6):671-6.
Chronic immune suppression is a risk for the development of post-transplantation lymphoproliferative disorders, which are frequently caused by a B-cell dyscrasia. We report a unique primary presentation of the rare angiotropic lymphoma in a kidney allograft, 18 years after transplantation. The diagnosis was made by a percutaneous allograft biopsy specimen when the recipient presented with renal dysfunction and intermittent hematuria. Immunostaining of the biopsy specimen revealed a T-cell lineage of the neoplastic cells rather than the more common B-cell source. At the time of biopsy, there was no evidence of systemic dissemination of lymphoma. The intragraft lymphoma resolved completely after chemotherapy, but the patient died 6 months later as a result of an intracerebral hemorrhage. At autopsy, intravascular lymphoma was only found in the cerebral vessels. To the authors' knowledge, this is the first report of angiotropic T-cell lymphoma in a kidney allograft. A description of the clinical, pathologic, and immunohistochemical features of this case is provided, as well as reviews of previous reports of renal angiotropic lymphoma and post-transplantation T-cell lymphomas.
慢性免疫抑制是移植后淋巴组织增生性疾病发生的一个危险因素,这些疾病通常由B细胞发育异常引起。我们报告了1例肾移植术后18年出现的罕见血管中心性淋巴瘤的独特首发表现。当受者出现肾功能不全和间歇性血尿时,通过经皮移植肾活检标本做出诊断。活检标本的免疫染色显示肿瘤细胞为T细胞谱系,而非更常见的B细胞来源。活检时,没有淋巴瘤全身播散的证据。移植肾内的淋巴瘤在化疗后完全消退,但患者6个月后因脑出血死亡。尸检时,仅在脑血管中发现血管内淋巴瘤。据作者所知,这是肾移植中血管中心性T细胞淋巴瘤的首例报告。本文提供了该病例的临床、病理和免疫组化特征描述,以及对既往肾血管中心性淋巴瘤和移植后T细胞淋巴瘤报告的综述。